Company intelligence / Profile preview

Ozette

Seattle, Washington, United Statesozette.com ↗

Ownership: Private
Employees: ~11
Development stage: Commercial

Overview

Ozette does not develop its own drugs but provides an AI-powered platform that accelerates the discovery and development of therapies by enabling deep immune profiling from preclinical research through FDA approval. Its technology has been used in academic and biopharma settings to analyze complex single-cell datasets with unprecedented speed, depth, and reproducibility

Therapeutic areas: OncologyImmunologyInfectious Diseases
Modalities: Cell therapy (enabling technology for cell-based therapies)Platform/Software (AI-driven computational analysis of single-cell data)
Industry: Drug Discovery Services

Partnerships

Bloodworks Northwest/Bloodworks Bio (collaboration on blood donor immune profiling for cell therapy development)

Beyond the preview

Go deeper on Ozette.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ozette.

Explore the full profile